Answers are grounded in this paper and cite their sources.
Finds M. restricta-derived extracellular vesicles accelerate tumor growth in epithelial ovarian cancer, highlighting a novel fungal-immune axis.
The intratumoural mycobiome is a critical constituent of the tumour microenvironment; however, its specific impact on epithelial ovarian cancer (EOC) progression and the underlying molecular mechanisms remain largely elusive. In this study, internal transcribed spacer 1 (ITS1) sequencing revealed a significant enrichment of Malassezia in EOC tissues compared with epithelial borderline ovarian tumours, with its abundance positively correlated with disease progression. Subsequent intratumoural microbiota transplantation and mono-colonisation in a murine EOC model demonstrated that Malassezia restricta substantially accelerated tumour growth and increased M2 macrophage infiltration. Furthermore, in vitro assays established that M. restricta-derived extracellular vesicles (MrEVs) play a pivotal role in inducing M2 macrophage polarisation. Mechanistically, both in vitro and in vivo data showed that MrEVs activate the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signalling pathway, thereby driving M2 polarisation and tumour malignancy. Collectively, these findings identify M. restricta as a pro-tumourigenic fungus in EOC and uncover a previously unrecognised fungal-immune axis that promotes tumour progression. This study provides new insight into the oncogenic role of tumour-resident fungi and highlights the M. restricta EV-JAK2/STAT3 axis as a potential therapeutic target for immune modulation.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: